City is location of Maraganore’s next RNAi play

John Maraganore is getting back into RNAi, but this time as executive chair of newco City.

With $135 million raised in a series A round, the co-founder and former CEO of RNAi leader Alnylam Inc. (NASDAQ:ALNY) is looking to build the next generation of siRNA molecules at Cambridge, Mass.-based City Therapeutics Inc. The round was led by Arch Venture Partners, where Maraganore is also a venture partner...